NEWS

Supply chain headaches curb ResMed’s ability to meet demand

MELBOURNE: Sleep treatments maker ResMed says there is no way it can keep up with… read more

Eucalyptus raises $60m eyes off new obesity management drugs

SYDNEY: One of Silicon Valley’s most respected technology investors has led a $60 million funding… read more

Psychedelics trials ramp up despite TGA decision

PERTH: Australian psychedelic drug experiments will continue despite the Therapeutic Goods Administration rejecting a bid… read more

20 new senior healthcare executives sought for key roles

MELBOURNE: Twenty senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more